8-isopropyl-5,6,7,8-tetrahydro-quinazoline | 1404306-36-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 8-isopropyl-5,6,7,8-tetrahydro-quinazoline
• 英文别名: 8-propan-2-yl-5,6,7,8-tetrahydroquinazoline
• CAS: 1404306-36-0
• 化学式: C₁₁H₁₆N₂
• 分子量: 176.261
• InChiKey: HFOFFUFJLSWZNP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-异丙基环己酮 、 醋酸甲脒 在 硫酸 、 正丁醇 、 crude product 作用下， 以 正丁醇 为溶剂， 反应 24.0h， 以Product 8-isopropyl-5,6,7,8-tetrahydro-quinazoline (˜5 g) is obtained的产率得到8-isopropyl-5,6,7,8-tetrahydro-quinazoline
  参考文献：
  名称：

  Pyrimidine derivatives and their use in perfume compositions

  摘要：

  本发明涉及新型嘧啶衍生物及其在香料组合物中的使用。本发明的新型嘧啶衍生物由以下公式表示：其中m和n是整数，当m为0时，n为1；当m为1时，n为0或1；或当m为2时，n为0；其中(CH)m和(CH)n各自独立地可选地被取代为从甲基和乙基组成的群体中选择的取代基；其中X从N、O和S中选择；且其中R1和R2各自独立地代表氢或一个碳氢基团，或者R1和R2一起代表一个融合环或一个环系统，但当R1为氢时，R2不为氢。

  公开号：

  US08557876B2

文献信息

• SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
  申请人：BlinkBio, Inc.

  公开号：US20170202970A1

  公开（公告）日：2017-07-20

  Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.

  本文描述了基于硅的共轭物，能够将一个或多个有效载荷基团传递到靶细胞或组织。考虑到的共轭物可能包括一个硅-杂原子核心，一个或多个可选的催化基团，一个定位基团，允许共轭物在靶细胞或组织内积累，一个或多个有效载荷基团（例如，治疗剂或成像剂），以及与硅-杂原子核心共价结合的两个或更多个不干扰基团。
• 2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS
  申请人：Aicher Thomas Daniel

  公开号：US20100105659A1

  公开（公告）日：2010-04-29

  Provided are compounds that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes mellitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.

  提供了一些化合物，这些化合物在治疗和/或预防由葡萄糖激酶活性不足引起的疾病中非常有用，例如糖尿病。同时提供了治疗或预防由葡萄糖激酶活性不足或可以通过激活葡萄糖激酶治疗的疾病和疾病的方法。
• Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
  申请人：Aicher Thomas Daniel

  公开号：US20100204240A1

  公开（公告）日：2010-08-12

  Provided are compounds of Formula (I): wherein R 2 , R 3 , R 13 , L and D 2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.

  提供的化合物式(I)如下：其中R2、R3、R13、L和D2如规范中所定义，这些化合物可用于治疗和/或预防由于葡萄糖激酶活性不足引起或可以通过激活葡萄糖激酶治疗的疾病或紊乱，包括但不限于糖尿病、糖耐量受损、IFG（空腹血糖受损）和IFG（空腹高血糖），以及本文所讨论的其他疾病和紊乱。
• Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
  申请人：AICHER Thomas Daniel

  公开号：US20120277242A1

  公开（公告）日：2012-11-01

  Provided are compounds of Formula (I): wherein R 2 , R 3 , R 13 , L and D 2 are as defined in the specification, which are useful in the treatment and/or prevention of diseases or disorders mediated by deficient levels of glucokinase activity or which can be treated by activating glucokinase including, but not limited to, diabetes mellitus, impaired glucose tolerance, IFG (impaired fasting glucose) and IFG (impaired fasting glycemia), as well as other diseases and disorders such as those discussed herein.

  本发明提供了式(I)的化合物：其中R2、R3、R13、L和D2如规范中所定义，它们在治疗和/或预防由葡萄糖激酶活性不足介导的疾病或疾病中有用，或者可以通过激活葡萄糖激酶来治疗，包括但不限于糖尿病、糖耐量受损、IFG（空腹血糖受损）和IFG（空腹高血糖），以及其他疾病和疾病，如在此处所讨论的。
• NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN PERFUME COMPOSITIONS
  申请人：Belko Robert P.

  公开号：US20120277325A1

  公开（公告）日：2012-11-01

  The present invention relates to novel pyrimidine derivatives and their use in perfume compositions. The novel pyrimidine derivatives of the present invention are represented by the following formula: wherein m and n are integers that when m is 0, n is 1; when m is 1, n is 0 or 1; or when m is 2, n is 0; wherein (CH) m and (CH) n are each independently optionally substituted with a substituent selected from the group consisting of methyl and ethyl; wherein X is selected from the group consisting of N, O, and S; and wherein R 1 and R 2 each independently represent H or a hydrocarbon group, or R 1 and R 2 together represent a fused ring or a ring system, with the proviso that when R 1 is H, R 2 is not H.

  本发明涉及新型嘧啶衍生物及其在香料组合物中的使用。本发明的新型嘧啶衍生物由以下公式表示：其中m和n是整数，当m为0时，n为1；当m为1时，n为0或1；或当m为2时，n为0；其中(CH)m和(CH)n各自独立地可选地被取代为甲基和乙基中的一种取代基；其中X从N、O和S中选择；其中R1和R2各自独立地表示H或一个碳氢基团，或者R1和R2一起表示一个融合环或一个环系统，但当R1为H时，R2不为H。